TY - JOUR
T1 - Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type i IFN production
AU - Brehm, Anja
AU - Liu, Yin
AU - Sheikh, Afzal
AU - Marrero, Bernadette
AU - Omoyinmi, Ebun
AU - Zhou, Qing
AU - Montealegre, Gina
AU - Biancotto, Angelique
AU - Reinhardt, Adam
AU - De Jesus, Adriana Almeida
AU - Pelletier, Martin
AU - Tsai, Wanxia L.
AU - Remmers, Elaine F.
AU - Kardava, Lela
AU - Hill, Suvimol
AU - Kim, Hanna
AU - Lachmann, Helen J.
AU - Megarbane, Andre
AU - Chae, Jae Jin
AU - Brady, Jilian
AU - Castillo, Rhina D.
AU - Brown, Diane
AU - Casano, Angel Vera
AU - Gao, Ling
AU - Chapelle, Dawn
AU - Huang, Yan
AU - Stone, Deborah
AU - Chen, Yongqing
AU - Sotzny, Franziska
AU - Lee, Chyi Chia Richard
AU - Kastner, Daniel L.
AU - Torrelo, Antonio
AU - Zlotogorski, Abraham
AU - Moir, Susan
AU - Gadina, Massimo
AU - McCoy, Phil
AU - Wesley, Robert
AU - Rother, Kristina
AU - Hildebrand, Peter W.
AU - Brogan, Paul
AU - Krüger, Elke
AU - Aksentijevich, Ivona
AU - Goldbach-Mansky, Raphaela
PY - 2015/11/2
Y1 - 2015/11/2
N2 - Autosomal recessive mutations in proteasome subunit β 8 (PSMB8), which encodes the inducible proteasome subunit β5i, cause the immune-dysregulatory disease chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE), which is classified as a proteasome-associated autoinflammatory syndrome (PRAAS). Here, we identified 8 mutations in 4 proteasome genes, PSMA3 (encodes α7), PSMB4 (encodes β7), PSMB9 (encodes β1i), and proteasome maturation protein (POMP), that have not been previously associated with disease and 1 mutation in PSMB8 that has not been previously reported. One patient was compound heterozygous for PSMB4 mutations, 6 patients from 4 families were heterozygous for a missense mutation in 1 inducible proteasome subunit and a mutation in a constitutive proteasome subunit, and 1 patient was heterozygous for a POMP mutation, thus establishing a digenic and autosomal dominant inheritance pattern of PRAAS. Function evaluation revealed that these mutations variably affect transcription, protein expression, protein folding, proteasome assembly, and, ultimately, proteasome activity. Moreover, defects in proteasome formation and function were recapitulated by siRNA-mediated knockdown of the respective subunits in primary fibroblasts from healthy individuals. Patient-isolated hematopoietic and nonhematopoietic cells exhibited a strong IFN gene-expression signature, irrespective of genotype. Additionally, chemical proteasome inhibition or progressive depletion of proteasome subunit gene transcription with siRNA induced transcription of type I IFN genes in healthy control cells. Our results provide further insight into CANDLE genetics and link global proteasome dysfunction to increased type I IFN production.
AB - Autosomal recessive mutations in proteasome subunit β 8 (PSMB8), which encodes the inducible proteasome subunit β5i, cause the immune-dysregulatory disease chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE), which is classified as a proteasome-associated autoinflammatory syndrome (PRAAS). Here, we identified 8 mutations in 4 proteasome genes, PSMA3 (encodes α7), PSMB4 (encodes β7), PSMB9 (encodes β1i), and proteasome maturation protein (POMP), that have not been previously associated with disease and 1 mutation in PSMB8 that has not been previously reported. One patient was compound heterozygous for PSMB4 mutations, 6 patients from 4 families were heterozygous for a missense mutation in 1 inducible proteasome subunit and a mutation in a constitutive proteasome subunit, and 1 patient was heterozygous for a POMP mutation, thus establishing a digenic and autosomal dominant inheritance pattern of PRAAS. Function evaluation revealed that these mutations variably affect transcription, protein expression, protein folding, proteasome assembly, and, ultimately, proteasome activity. Moreover, defects in proteasome formation and function were recapitulated by siRNA-mediated knockdown of the respective subunits in primary fibroblasts from healthy individuals. Patient-isolated hematopoietic and nonhematopoietic cells exhibited a strong IFN gene-expression signature, irrespective of genotype. Additionally, chemical proteasome inhibition or progressive depletion of proteasome subunit gene transcription with siRNA induced transcription of type I IFN genes in healthy control cells. Our results provide further insight into CANDLE genetics and link global proteasome dysfunction to increased type I IFN production.
UR - http://www.scopus.com/inward/record.url?scp=84946780874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946780874&partnerID=8YFLogxK
U2 - 10.1172/JCI81260
DO - 10.1172/JCI81260
M3 - Article
C2 - 26524591
AN - SCOPUS:84946780874
SN - 0021-9738
VL - 125
SP - 4196
EP - 4211
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
ER -